Schedule of Operations by Reportable Segment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information [Line Items]
Revenue	$ 12,304,000	$ 4,469,000
Depreciation and amortization	3,266,000	514,000
Interest expense	1,378,000	20,000
Stock based compensation	4,000	7,000
Impairment of goodwill
Net income (loss) from continuing operations	(8,951,000)	(4,062,000)
Capital expenditures	942,000	72,000
Identifiable assets	281,859,000	141,823,000
Operating Segments [Member] | Product Packaging [Member]
Segment Reporting Information [Line Items]
Revenue	3,569,000	3,861,000
Depreciation and amortization	180,000	116,000
Interest expense	24,000	19,000
Stock based compensation	1,000	1,000
Impairment of goodwill
Net income (loss) from continuing operations	(42,000)	218,000
Capital expenditures	923,000	66,000
Identifiable assets	23,371,000	22,567,000
Operating Segments [Member] | Commercial Banking [Member]
Segment Reporting Information [Line Items]
Revenue	129,000
Depreciation and amortization
Interest expense
Stock based compensation
Impairment of goodwill
Net income (loss) from continuing operations	181,000
Capital expenditures
Identifiable assets	57,259,000
Operating Segments [Member] | Direct Marketing Online Sales [Member]
Segment Reporting Information [Line Items]
Revenue	6,932,000	608,000
Depreciation and amortization	49,000	44,000
Interest expense	687,000
Stock based compensation
Impairment of goodwill
Net income (loss) from continuing operations	(4,486,000)	(1,799,000)
Capital expenditures	2,000	6,000
Identifiable assets	45,788,000	18,892,000
Operating Segments [Member] | Biotechnology [Member]
Segment Reporting Information [Line Items]
Revenue
Depreciation and amortization	278,000	278,000
Interest expense
Stock based compensation
Impairment of goodwill
Net income (loss) from continuing operations	(616,000)	(698,000)
Capital expenditures
Identifiable assets	56,276,000	51,158,000
Operating Segments [Member] | Securities [Member]
Segment Reporting Information [Line Items]
Revenue	1,674,000
Depreciation and amortization	2,685,000
Interest expense	667,000
Stock based compensation
Impairment of goodwill
Net income (loss) from continuing operations	(2,508,000)
Capital expenditures	13,000
Identifiable assets	85,178,000
Operating Segments [Member] | Corporate Segment [Member]
Segment Reporting Information [Line Items]
Revenue
Depreciation and amortization	74,000	76,000
Interest expense		1,000
Stock based compensation	3,000	6,000
Impairment of goodwill
Net income (loss) from continuing operations	(1,480,000)	(1,783,000)
Capital expenditures	4,000
Identifiable assets	$ 13,987,000	$ 49,206,000